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DOI: 10.1039/c0nr00874eA gold nanocage and dye conjugate has been demonstrated for use
with photoacoustic imaging and fluorescence detection of protease
activity. The detection sensitivity could be maximized by using gold
nanocages with a localized surface plasmon resonance peak away
from the emission peak of the dye. These hybrids can be potentially
used as multimodal contrast agents for molecular imaging.Multimodal probes or contrast agents have garnered great interest in
biomedical imaging over the past few years.1,2 Among them,
inorganic nanoparticles have become versatile platforms due to their
unique and often tunable physical/chemical properties that can
enhance imaging contrast through different mechanisms.3 The
surfaces of inorganic nanoparticles can also be readily conjugated
with various functional groups for molecular imaging and targeted
delivery. To this end, tremendous efforts have been directed towards
quantum dots and iron oxide nanoparticles conjugated with func-
tional moieties for detection by PET/optical or MRI/optical dual
imaging modalities.4 There are only a few reports on the demon-
stration of multimodal probes based on Au nanoparticles and their
conjugates. In one example, a 2.4-nm Au nanoparticle was conju-
gated with Gd-DTPA on its surface at a density of 50 Gd per Au
nanoparticle and then used as a dual contrast agent for MRI/CT
imaging.5 In another example, the oligonucleotide-conjugated Au
nanoparticles were functionalized with Cy5.5 through the comple-
mentary oligonucleotides and then tested for fluorescence/reflectance
imaging application.6 Here we report a new probe based on Au
nanocages and fluorescence dyes coupled together through enzyme-
cleavable peptides. This new probe can be potentially used as a dual
contrast agent for photoacoustic/fluorescence imaging and therefore
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950 | Nanoscale, 2011, 3, 950–953In the previous studies, we have demonstrated Au nanocages —
nanostructures with hollow interiors and porous walls — as a plat-
form for various biomedical applications such as contrast enhance-
ment in optical imaging, photothermal therapy, and controlled
release.7 Owing to their tunable localized surface plasmon resonance
(LSPR, including both absorption and scattering) features in the
near-infrared (NIR) region and compact sizes (<50 nm), Au nanoc-
ages are good candidates as contrast agents for optical imaging. For
example, they can strongly absorb light in the NIR region and thus
drastically enhance the contrast for photoacoustic (PA) imaging.
When they were intravenously injected into rats, the optical absorp-
tion in the cerebral cortex could be increased by up to 81%.8 Gold
nanocages have also been explored as tracers for non-invasive lymph
node mapping with PA imaging at a depth of 33 mm below the skin
surface, making them well-suited for humans.9 When conjugated with
a targeting ligand, Au nanocages can triple the PA signals from
a tumor as compared to nanocages covered with poly(ethylene
glycol).10 In the present work, we attach fluorescent dyes to the
surface of Au nanocages via protease-cleavable peptides to construct
a new probe that can be used for PA imaging and simultaneous
detection of protease activity by fluorescence in the targeted lesion. In
the initial constructs, the fluorescence emitted by the dye molecules is
quenched due to energy transfer. However, in the presence of
a protease, the dye molecules will be cleaved and released from the
surface of the nanocage, and the fluorescence will be recovered. In
practice, the distribution of Au nanocages can be mapped by PA
imaging while the protease activity can be monitored by fluorescence
spectroscopy or microscopy. We chose the matrix metalloproteases
(MMPs) for our proof-of-concept experiments because they have
long been recognized as a biomarker associated with cancer cell
invasion and metastasis.11 For example, several clinical studies have
shown that breast cancer patients have high levels of expression of
MMPs, such as MMP-2, MMP-7, and MMP-9.12 More recent
studies indicated that metastatic lymph nodes of breast cancer
patients also overexpressed these enzymes.13 The probe demonstrated
here can be potentially used as a new class of multimodal contrast
agents for photoacoustic/fluorescence imaging in the diagnosis of
cancer metastasis.
Fig. 1 shows a schematic illustration of the MMP-sensitive probe
(dye–GKGPLGVRGC–Au nanocage) consisting of dye molecules
and a Au nanocage coupled together through a peptide specific to
MMP-2. Initially, the fluorescence emitted by the dye is quenched by
the Au nanocage due to nano-surface energy transfer (NSET)This journal is ª The Royal Society of Chemistry 2011
Fig. 1 A schematic illustration of the dual probe that could be activated
by an enzyme. The probe is comprised of a Au nanocage and fluorescent
dyes linked together through an enzyme cleavable peptides. The emission
from the dyes is initially quenched by the Au nanocage. Upon cleavage of
the peptide and release of the dye from the surface of Au nanocage, the
fluorescence of the dye is recovered.
Fig. 2 (a) Fluorescence spectra of FITC–GKGPLGVRGC–cage770
before and after KCN etching; (b) fluorescence spectra of FITC–
GKGPLGVRGC–cage770 before and after incubation with 1 U (72 ng




















































View Onlinemechanism. Similar to F€orster resonance energy transfer (FRET),
the excited state of the dye molecule (donor) can non-radiatively
transfer its energy to a metal nanoparticle (acceptor) through the
dye’s dipole and the nearly free conduction electrons in the metal.14
Compared to FRET, the probability of the dipolar interactions for
NSET is much greater because the conduction electrons in the metal
nanoparticle can provide numerous dipole vectors on its surface to
readily accept energy from the donor. Thus, the efficiency of NSET is
much higher than FRET, typically close to 100% within the energy
transfer distance. Additionally, the energy transfer distance in NSET
is nearly twice as long as the typical F€orster distance (<10 nm) in
FRET because NSET has a 1/d4 dependence on distance as opposed
to 1/d6 relationship for FRET.15 Previous studies have shown that if
the donor (i.e., dye) and acceptor (i.e., Au nanoparticle) are con-
nected through a single-stranded DNA (ssDNA) spacer, such a probe
can be ‘‘turned on’’ by changing from a hairpin structure to a rod-like
structure of ssDNA and used for the detection of DNA
mismatches.16 For another system, the dyes leave the surface of Au
nanoparticles after cleavage by an enzyme, and their fluorescence is
recovered.17
To fabricate the MMP-responsive probe, we conjugated a FITC-
labeled C-terminus peptide (FITC–GKGPLGVRGC–NH2,
GenScript, NJ) to the surfaces of Au nanocages (with an LSPR peak
at 770 nm) through the free thiol group on the side chain of cysteine.
The final product is denoted by FITC–GKGPLGVRGC–cage770.
The sequence italicized in the peptide can be cleaved by MMP-2,
a key protease expressed in tumors at much higher levels than in the
healthy tissues. Briefly, 100 mL of 1 mM FITC-labeled peptide in
DMF solution (0.1 mmol) was added to 1 mL of aqueous 1 nM
cage770 solution (0.1 pmol) and incubated at room temperature for
24 h, followed by washing five times with 10 mM phosphate buffered
saline (PBS, pH 7.4) to remove the excess peptide. To quantify the
number of peptides conjugated to each nanocage, aqueous KCN
solution at a final concentration of 100 mM was used to completely
dissolve the Au nanocages, resulting in the release of all peptides from
the nanocages into the surroundings. In Fig. 2a, the curves in green,
red, and black represent fluorescence spectra taken from an aqueous
suspension of cage770, and suspensions of the FITC–
GKGPLGVRGC–cage770 (at a final concentration of 7 pM) before
and after KCN etching, respectively. By comparing the fluorescence
intensity with a calibration curve for the FITC-labeled peptide inThis journal is ª The Royal Society of Chemistry 2011Fig. S1†, we can estimate the number of peptides per nanocage and
the NSET quenching efficiency. There were approximately 1.8 104
peptides, on average, conjugated to the surface of each Au nanocage.
We obtained a quenching efficiency of 96.6% by comparing fluores-
cence intensities before and after the FITC-labeled peptides had been
released from the surfaces of the nanocages.
To demonstrate the ability to detect MMP-2 enzyme activity, we
incubated the FITC–GKGPLGVRGC–cage770 conjugate with
MMP-2 enzyme (an activated full-length, recombinant, human
MMP-2 expressed by CHO cells, EMD Chemicals, NJ). Briefly, 2
mL of 10 pM FITC–GKGPLGVRGC–cage770 (20 fmol) in PBS
was incubated with the active MMP-2 (1 U, 72 ng mL1) at 37 C for
3 h. Prior to enzyme cleavage, the fluorescence intensity of the
solution was read as 18. After incubation with the MMP-2 enzyme
for 3 h, the fluorescence dramatically increased to 69, about 4 times
(280% increase in fluorescence intensity) stronger than what was
observed before incubation with the enzyme (Fig. 2b).
We then examined the time dependence of enzyme activity using
the same imaging probe. In this case, 20 fmol FITC–
GKGPLGVRGC–cage770 in 2 mL PBS was incubated with the
active MMP-2 (1 U, 72 ng mL1) at 37 C for different periods of
time. The fluorescence intensity was linearly proportional to the
incubation time in the period from 10 to 120 min and began to level
off after 6 h (Fig. 3a). We also investigated the cleavage of FITC–
GKGPLGVRGC–cage770 (20 fmol) with a fixed incubation time of
12 h but with different enzyme activities (Fig. 3b). The cleavage
efficiency increased sharply below 1 U, but gradually leveled off. This
result suggests that 1 U enzyme activity was sufficient to almost fully
catalyze the cleavage of peptides in 20 fmol FITC–
GKGPLGVRGC–cage770 during incubation. Fig. 3b also showsNanoscale, 2011, 3, 950–953 | 951
Fig. 3 Characterization of the FITC–GKGPLGVRGC–cage770 probe:
(a) percentage increase in fluorescence intensity when the FITC–
GKGPLGVRGC–cage770 sample (20 fmol) was incubated with 1 U of
MMP-2 as a function of time; (b) percentage increase in fluorescence
intensity as a function of MMP-2 activity (20 fmol cage770–peptide–
FITC, 12 h incubation); and (c) percentage increase in fluorescence
intensity (1 U MMP-2, 20 fmol FITC–GKGPLGVRGC–cage770, 2 h
incubation) as a function of MMP inhibitor concentration. The 50%
inhibitory concentration in this assay was about 300 pM. Percentage
increase in fluorescence intensity was defined as the change in fluores-
cence intensity divided by the initial fluorescence intensity.
Fig. 4 Fluorescence images of FITC–GKGPLGVRGC–cage770 after
incubation with different concentrations of MMP-2 at 37 C for 12 h. The




















































View Onlinethat 20 fmol of FITC–GKGPLGVRGC–cage770 probe can be used
to detect the enzyme activity down to 0.01 U, corresponding to
a sensitivity of 0.72 ng mL1. To test the resistance of FITC–
GKGPLGVRGC–cage770 probe against relevant inhibitors, we
chose N-[(2R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl]-
L-tryptophan (galardin), a potent cell-permeable MMP inhibitor with
a molecular weight of 388.5, and performed dose-dependent experi-
ments. We added various amounts of galardin up to 1 mM to the
mixture of MMP-2 (1 U) and FITC–GKGPLGVRGC–cage770
(20 fmol), and then incubated for 2 h. Fig. 3c shows the dose–
response study of galardin-mediated MMP inhibition. The inhibitory
effect was approximately 72% when 1 mM of inhibitor was used. The
Ki was estimated to be 300 pM, similar to the value reported in
literature.18
Finally, we embedded the mixture of FITC–GKGPLGVRGC–
cage770 and MMP-2 in an agarose gel and performed a fluorescence952 | Nanoscale, 2011, 3, 950–953imaging study. Briefly, 1 mL of FITC–GKGPLGVRGC–cage770
(20 pmol) was incubated with different doses of MMP-2 at 37 C for
12 h. Then, 60 mL of the solution were mixed with 30 mL of 1.5%
agarose, which was preheated at 90 C for 1 h and immediately
transferred into the wells of a 96-well plate. The mixture was allowed
to cool to room temperature and solidified into gel within 15 min. We
then took fluorescence micrographs using a QICAM Fast Cooled
Mono 12-bit camera (Q Imaging, Burnaby, BC, Canada) attached to
a fluorescence microscope (Olympus). All the images were captured
with the same exposure parameters using Capture 2.90.1 and then
converted into color images in Photoshop (Adobe). Fig. 4 shows
fluorescence images of gel samples at various enzyme concentrations
ranging from 0 to 10 U. The controls, plain agarose and agarose
containing FITC–GKGPLGVRGC–cage770 with no MMP-2 dis-
played very similar, low fluorescence intensities. When 0.1 U (9 ng
mL1) of MMP-2 was applied to the sample, a slightly brighter color
than those of the controls was observed, indicating that MMP-2
could be detected at a concentration of 9 ng mL1. As the concen-
tration of MMP-2 increased, the corresponding images became
brighter. This result suggests the potential use of the dye–
GKGPLGVRGC–Au nanocage probe in in vivo imaging of enzyme
concentration or activity.
The NSET phenomenon always occurs when a dye molecule is in
proximity to the metal nanoparticle regardless of the overlap between
the emission spectrum of the dye and the LSPR peak of the nano-
particle. However, the fluorescence intensity of the free dyes strongly
depends on the concentration of Au nanocages in the solution, as well
as the spectral overlap between the fluorophore and the nano-
particle.19 We have studied different combinations of two fluorescent
dyes (fluorescein isothiocyanate or FITC and Alexa Fluor 790 or
AF790) and 45-nm Au nanocages with LSPR peaked at two different
wavelengths, 645 nm and 770 nm (cage645 and cage770, respectively).
The results are shown in Fig. 5a and b. For FITC (ex. at 488 nm, and
em. at 518 nm) at a concentration of 0.1 mM, the fluorescence
intensity decreased as the concentration of Au nanocages increased
(Fig. 5c). At a nanocage concentration of 10 pM, the fluorescence
intensity of FITC dropped by 50% and 25% for cage645 and cage770,
respectively, relative to the control sample without nanocages. A
similar trend was also observed for AF790 (ex. at 780 nm and em. at
804 nm). At a nanocage concentration of 10 pM, the fluorescence
intensity of AF790 (1 mM) decreased by 50% and 37.5% for cage770
and cage645, respectively, relative to the sample containing no
nanocages. The decrease of fluorescence intensity in the presence of
nanocages could be attributed to two factors: static quenching caused
by diffusion of the free dyes to the surface of the nanocages and
absorption of the nanocage at the emission wavelength of the dye.20
To maximize the intensity of emission from the free dye, the LSPR
peak of the nanocages has to be tuned away from the emission peakThis journal is ª The Royal Society of Chemistry 2011
Fig. 5 Spectroscopic characterization of the Au nanocages and dyes: (a)
excitation and emission spectra of FITC and extinction spectrum of Au
nanocages with LSPR peaked at 770 nm (cage770); and (b) excitation and
emission spectra of Alexa Fluor 790 (AF790) and extinction spectrum of
Au nanocages with LSPR peaked at 645 nm (cage645). (c, d) Plots of the
fluorescence intensity as a function of nanocage concentration where
a specific amount of the dye was mixed with the Au nanocages of different
concentrations in aqueous solutions: (c) FITC at a final concentration of




















































View Onlineof the dye. Hence, a combination of FITC–cage770 or AF790–
cage645 would be an optimal choice for maximizing the detection
sensitivity of the system. In addition, the concentration of nanocages
should be kept below 10 pM to ensure a fluorescence recovery of
>78% for FITC–cage770.
In conclusion, we have demonstrated an enzyme-sensitive probe
that is comprised of a Au nanocage and dye molecules linked
together through an enzyme-cleavable peptide. By tuning the LSPR
peak of the Au nanocage away from the emission peak of the dye, the
fluorescence from the released dyes could be detected with relatively
high sensitivity. The FITC–GKGPLGVRGC–cage770 probe was
chosen as a model system for the detection of MMP-2. Both the
fluorescence spectroscopy and microscopy studies show a high
quenching efficiency for the dye and a high sensitivity in response to
a relatively low concentration of enzyme and low enzyme activity.
Due to the optical tunability of the nanocages in the NIR region, it is
flexible to choose different dyes and nanocages to construct probes
best-suited for in vivo imaging of cells and enzyme activities. This
multimodal probe could enable cancer detection by photoacoustic
imaging, cancer diagnosis by NIR fluorescence imaging, as well as
cancer treatment by photothermal effect.Acknowledgements
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